Average Co-Inventor Count = 10.80
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pfizer Corporation (7 from 4,455 patents)
2. Mirati Therapeutics, Inc. (7 from 38 patents)
3. Takeda Pharmaceutical Company Limited (5 from 1,179 patents)
4. Array Biopharma Inc. (2 from 329 patents)
5. Cardurion Pharmaceuticals, LLC (2 from 10 patents)
6. Astrazeneca Ab (1 from 1,500 patents)
22 patents:
1. 12421253 - Tetrahydropyridopyrimidine pan-KRas inhibitors
2. 12398154 - Azaquinazoline pan-KRas inhibitors
3. 12304915 - SOS1 inhibitors
4. 12202836 - Bicyclic-fused heteroaryl or aryl compounds
5. 11999753 - Tetrahydropyridopyrimidine pan-KRas inhibitors
6. 11964989 - KRas G12D inhibitors
7. 11702424 - Bicyclic-fused heteroaryl or aryl compounds
8. 11702418 - SOS1 inhibitors
9. 11453683 - KRas G12D inhibitors
10. 11197858 - Substituted amines for treating cardiac diseases
11. 10793579 - Bicyclic-fused heteroaryl or aryl compounds
12. 10543212 - Substituted amines for treating cardiac diseases
13. 10407409 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
14. 10329302 - Bicyclic-fused heteroaryl or aryl compounds
15. 10308615 - Heterocyclic compounds as inhibitors of Vanin-1 enzyme